Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms

K. G. Cho, T. Nagashima, S. Barnwell, T. Hoshino

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Paraffin-embedded specimens of brain tumors from 256 patients who had received an intravenous infusion of bromodeoxyuiridine (BUdR) at the time of craniotomy were analyzed retrospectively by flow cytometry to determine the modal deoxyribonucleic acid (DNA) population. A single G1 peak was considered to represent a unimodal DNA population; two or more G1 peaks indicated a multimodal population. Most of the pituitary tumors and moderately anaplastic astrocytomas had unimodal DNA populations, whereas a higher percentage of other slow-growing tumors, such as meningiomas, ependymomas, and neurilemomas, had multimodal populations (46.2%, 50.0%, and 60.0%, respectively). A relatively high percentage of the rapidly growing or highly malignant brain tumors, including highly anaplastic astrocytomas, glioblastomas multiforme, metatatic tumors, and medulloblastomas, also had multimodal populations (52.9%, 48.7%, 57.1%, and 66.7%, respectively). In most tumor groups, however, the percentage of tumors with a multimodal DNA population did not correlate with the BUdR labeling index or with the percentage of BUdR-labeled-S-phase cells. Thus, modal DNA analysis by flow cytometry may provide information about the degree of heterogeneity and the biological behavior of individual brain tumors, but the results do not necessarily correlate with the rate of tumor growth or the prognosis in individual patients.

Original languageEnglish (US)
Pages (from-to)588-592
Number of pages5
JournalJournal of Neurosurgery
Volume69
Issue number4
StatePublished - 1988
Externally publishedYes

Fingerprint

Brain Neoplasms
DNA
Population
Bromodeoxyuridine
Astrocytoma
Neoplasms
Flow Cytometry
Ependymoma
Medulloblastoma
Craniotomy
Neurilemmoma
Pituitary Neoplasms
Meningioma
Glioblastoma
S Phase
Intravenous Infusions
Paraffin
Growth

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms. / Cho, K. G.; Nagashima, T.; Barnwell, S.; Hoshino, T.

In: Journal of Neurosurgery, Vol. 69, No. 4, 1988, p. 588-592.

Research output: Contribution to journalArticle

Cho, K. G. ; Nagashima, T. ; Barnwell, S. ; Hoshino, T. / Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms. In: Journal of Neurosurgery. 1988 ; Vol. 69, No. 4. pp. 588-592.
@article{c8b98b6379c84bf684549413e44f835d,
title = "Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms",
abstract = "Paraffin-embedded specimens of brain tumors from 256 patients who had received an intravenous infusion of bromodeoxyuiridine (BUdR) at the time of craniotomy were analyzed retrospectively by flow cytometry to determine the modal deoxyribonucleic acid (DNA) population. A single G1 peak was considered to represent a unimodal DNA population; two or more G1 peaks indicated a multimodal population. Most of the pituitary tumors and moderately anaplastic astrocytomas had unimodal DNA populations, whereas a higher percentage of other slow-growing tumors, such as meningiomas, ependymomas, and neurilemomas, had multimodal populations (46.2{\%}, 50.0{\%}, and 60.0{\%}, respectively). A relatively high percentage of the rapidly growing or highly malignant brain tumors, including highly anaplastic astrocytomas, glioblastomas multiforme, metatatic tumors, and medulloblastomas, also had multimodal populations (52.9{\%}, 48.7{\%}, 57.1{\%}, and 66.7{\%}, respectively). In most tumor groups, however, the percentage of tumors with a multimodal DNA population did not correlate with the BUdR labeling index or with the percentage of BUdR-labeled-S-phase cells. Thus, modal DNA analysis by flow cytometry may provide information about the degree of heterogeneity and the biological behavior of individual brain tumors, but the results do not necessarily correlate with the rate of tumor growth or the prognosis in individual patients.",
author = "Cho, {K. G.} and T. Nagashima and S. Barnwell and T. Hoshino",
year = "1988",
language = "English (US)",
volume = "69",
pages = "588--592",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "4",

}

TY - JOUR

T1 - Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms

AU - Cho, K. G.

AU - Nagashima, T.

AU - Barnwell, S.

AU - Hoshino, T.

PY - 1988

Y1 - 1988

N2 - Paraffin-embedded specimens of brain tumors from 256 patients who had received an intravenous infusion of bromodeoxyuiridine (BUdR) at the time of craniotomy were analyzed retrospectively by flow cytometry to determine the modal deoxyribonucleic acid (DNA) population. A single G1 peak was considered to represent a unimodal DNA population; two or more G1 peaks indicated a multimodal population. Most of the pituitary tumors and moderately anaplastic astrocytomas had unimodal DNA populations, whereas a higher percentage of other slow-growing tumors, such as meningiomas, ependymomas, and neurilemomas, had multimodal populations (46.2%, 50.0%, and 60.0%, respectively). A relatively high percentage of the rapidly growing or highly malignant brain tumors, including highly anaplastic astrocytomas, glioblastomas multiforme, metatatic tumors, and medulloblastomas, also had multimodal populations (52.9%, 48.7%, 57.1%, and 66.7%, respectively). In most tumor groups, however, the percentage of tumors with a multimodal DNA population did not correlate with the BUdR labeling index or with the percentage of BUdR-labeled-S-phase cells. Thus, modal DNA analysis by flow cytometry may provide information about the degree of heterogeneity and the biological behavior of individual brain tumors, but the results do not necessarily correlate with the rate of tumor growth or the prognosis in individual patients.

AB - Paraffin-embedded specimens of brain tumors from 256 patients who had received an intravenous infusion of bromodeoxyuiridine (BUdR) at the time of craniotomy were analyzed retrospectively by flow cytometry to determine the modal deoxyribonucleic acid (DNA) population. A single G1 peak was considered to represent a unimodal DNA population; two or more G1 peaks indicated a multimodal population. Most of the pituitary tumors and moderately anaplastic astrocytomas had unimodal DNA populations, whereas a higher percentage of other slow-growing tumors, such as meningiomas, ependymomas, and neurilemomas, had multimodal populations (46.2%, 50.0%, and 60.0%, respectively). A relatively high percentage of the rapidly growing or highly malignant brain tumors, including highly anaplastic astrocytomas, glioblastomas multiforme, metatatic tumors, and medulloblastomas, also had multimodal populations (52.9%, 48.7%, 57.1%, and 66.7%, respectively). In most tumor groups, however, the percentage of tumors with a multimodal DNA population did not correlate with the BUdR labeling index or with the percentage of BUdR-labeled-S-phase cells. Thus, modal DNA analysis by flow cytometry may provide information about the degree of heterogeneity and the biological behavior of individual brain tumors, but the results do not necessarily correlate with the rate of tumor growth or the prognosis in individual patients.

UR - http://www.scopus.com/inward/record.url?scp=0023815016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023815016&partnerID=8YFLogxK

M3 - Article

C2 - 3418392

AN - SCOPUS:0023815016

VL - 69

SP - 588

EP - 592

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 4

ER -